Yes, Bupropion Commonly Causes Both Headache and Nausea
Bupropion is well-documented to cause both headache and nausea as common adverse effects, though these symptoms occur less frequently than with some other antidepressants. These are recognized side effects across all formulations (immediate-release, sustained-release, and extended-release).
Evidence from FDA Drug Labeling
The FDA-approved prescribing information explicitly lists both symptoms among the most commonly observed adverse reactions 1:
- Headache appears as one of the most commonly reported adverse events across clinical trials
- Nausea occurred in controlled trials at rates of 2-4% with bupropion sustained-release versus 2% with placebo, and was among the most common reasons for treatment discontinuation 1
- In seasonal affective disorder trials, headache led to discontinuation in 1% of patients on bupropion 1
Comparative Context from Guidelines
The American College of Physicians guideline on second-generation antidepressants provides important comparative context 2:
- Headache, dizziness, and nausea are listed among the most commonly reported adverse events across all second-generation antidepressants
- Notably, bupropion had a lower rate of diarrhea compared to sertraline and other SSRIs, suggesting its gastrointestinal side effect profile may be somewhat more favorable than SSRIs
- Nausea and vomiting were the most common reasons for discontinuation across all antidepressant classes
Recent Clinical Evidence
Contemporary research confirms these findings in real-world practice:
- A 2023 study on dextromethorphan-bupropion combination listed headache and nausea among the most common adverse effects 3
- A 2019 comprehensive review identified headache, nausea, insomnia, and agitation as commonly reported adverse effects 4
- A 2012 large retrospective claims study (n=40,017) found headache rates up to 17 per 1,000 person-months of therapy, though patients taking bupropion were actually less likely to experience headaches compared to those taking SSRIs (HR = 0.78 for adults, 0.43 for adolescents) 5
Clinical Implications
These side effects typically occur early in treatment and are generally mild to moderate in severity. The term "heaviness of head" likely describes the headache symptom patients experience. While these are recognized adverse effects:
- They rarely lead to discontinuation (1% for headache in SAD trials)
- Bupropion's overall tolerability profile may be more favorable than SSRIs for these specific symptoms
- These effects should be monitored but do not typically require medication discontinuation unless severe
Important Caveat
If a patient develops severe or persistent headache with nausea, consider other serious adverse events that require immediate evaluation, including hypertension (which bupropion can cause) or, rarely, seizures (for which bupropion carries increased risk) 1.